Accelerated iTBS for Depression: Monitoring Brain Hemodynamics With Simultaneous iTBS/fNIRS
1 other identifier
interventional
1
1 country
1
Brief Summary
This study will investigate the cortical hemodynamic response variability of an accelerated form of TBS stimulation over left dorsolateral prefrontal cortex (DLPFC) using a concurrent TBS/fNIRS setup. The accelerating TMS protocol that will be used in this study is similar to the Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT), i.e., fifty iTBS sessions (1,800 pulses per session, 50-minute intersession interval) will be delivered as 10 daily sessions over 5 consecutive days at 90% resting motor threshold. The investigators will recruit a depressed patient and conduct a concurrent iTBS/fNIRS protocol for each iTBS session. Moreover, the depression symptoms of the patient will be assessed before and after treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable depression
Started Mar 2025
Shorter than P25 for not_applicable depression
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 19, 2025
CompletedFirst Submitted
Initial submission to the registry
April 27, 2025
CompletedFirst Posted
Study publicly available on registry
May 14, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2025
CompletedMay 14, 2025
May 1, 2025
2 months
April 27, 2025
May 6, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Oxygenated and deoxygenated hemoglobin (HbO and HbR) change compared to baseline
iTBS-induced HbO and HbR change in the DLPFC before, during and after stimulation
Before, during and immediately after the intervention
Hamilton Depression Rating Scale (HAM-D)
The Hamilton Depression Rating Scale, 17 item (HAM-D-17) is a simple, clinician-administered tool used to assess symptoms of depression experienced by a patient in the past week. The values of HAM-D-17 range from 0 to 52, and higher socres mean more severe symptoms.
through study completion, an average of 5 days
Secondary Outcomes (3)
Montgomery-Asberg depression rating scale (MADRS)
through study completion, an average of 5 days
Patient Health Questionnaire-9 (PHQ-9)
daily for 5 days
Verbal Analogue Scale (VAS) fatigue and pain level
immediately after the intervention
Study Arms (1)
Accelerating TMS teatment
EXPERIMENTALOne depressed patient will be included in this study, which lasts for 5 consecutive days. During these 5 days, the participant will receive accelerated TMS treatment based on SAINT protocol, simultaneously monitored by concurrent TMS/fNIRS.
Interventions
Fifty iTBS sessions (1,800 pulses per session, 50-minute intersession interval) will be delivered as 10 daily sessions over 5 consecutive days at 90% resting motor threshold.
Eligibility Criteria
You may qualify if:
- aged 18 to 65;
- a clinical diagnosis of current nonpsychotic major depressive disorder by an experienced psychiatrist according to DSM-IV;
- no or stable (≥2 weeks) psychopharmacological medication;
- have not responded to at least one antidepressant medication;
- have not received any TMS treatment;
- and have a 17-item HAMD score ≥ 20.
You may not qualify if:
- severe internal diseases;
- neurological disorders or a history of severe head injuries;
- having suicidal ideation;
- pregnancy;
- antiepileptics and benzodiazepines corresponding to a dose of \>1 mg lorazepam/d.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Hong Kong Polytechnic University
Hong Kong, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Georg Kranz, PhD
The Hong Kong Polytechnic University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 27, 2025
First Posted
May 14, 2025
Study Start
March 19, 2025
Primary Completion
May 31, 2025
Study Completion
June 30, 2025
Last Updated
May 14, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share